Apoptosis is associated with various myocardial diseases. Angiotensin II (Ang II) plays a central role in the pathogenesis of RAAS-triggered cardiac apoptosis. Our previous studies showed that mammalian Ste20-like kinase 1 (Mst1) aggravates cardiac dysfunction in cardiomyocyte under pathological conditions, but its role in Ang IImediated cardiomyocyte apoptosis is not known. We addressed this in the present study by investigating whether cardiac-specific Mst1 knockout can alleviate Ang IIinduced cardiomyocyte apoptosis along with the underlying mechanisms. In vitro and in vivo experiments showed that Ang II increased intracellular reactive oxygen species (ROS) production and cardiomyocyte apoptosis; these were reversed by administration of the ROS scavenger N-acetylcysteine and by Mst1 deficiency, which suppressed c-Jun N-terminal kinase (JNK) phosphorylation and downstream signaling. Interestingly, Mst1 knockout failed to alleviate Ang II-induced phosphorylation of extracellular signal-regulated kinase 1/2, and inactivated apoptosis signal-regulating kinase1 (ASK1) by promoting its association with thioredoxin (Trx), which reversed the Ang II-induced activation of the ASK1-JNK pathway and suppressed Ang II-induced cardiomyocyte apoptosis. Thus, cardiac-specific Mst1 knockout inhibits ROS-mediated JNK signalling to block Ang II-induced cardiomyocyte apoptosis, suggesting Mst1 as a potential therapeutic target for treatment of RAAS-activated heart failure.
Mitogen-activated protein kinases (MAPKs) are a conserved family of serine/threonine protein kinases that are involved in many physiological and pathological processes. 10, 11 MAPKs include extracellular signal-regulated kinase (ERK) 1/2, c-Jun N-terminal kinase (JNK), and P38. Inhibition of JNK and ERK1/2 has been shown to block cardiac apoptosis. 12 Apoptosis signal-regulating kinase 1 (ASK1), a MAPK kinase kinase that is activated by various types of pathological stimuli including Ang II-induced oxidative stress, can activate JNK signalling to induce cell apoptosis. [13] [14] [15] [16] Thioredoxin (Trx) is a redox regulatory protein that inhibits the kinase activity of ASK1 by directly binding to its N terminus. 15, 17 ROS production induced by Ang II results in the dissociation of ASK1 from Trx and sequent apoptosis via JNK signalling.
Thus, inhibiting ASK1 activity by targeting Trx is a potential therapeutic strategy to counteract Ang II-triggered cardiomyocyte apoptosis.
Mammalian Ste20-like kinase (Mst) 1 is a serine-threonine kinase and a component of the Hippo signalling pathway that has been shown to promote apoptosis and induce HF. 18 Our previous studies suggested a potential role for Mst1 in regulating cardiomyocyte autophagy; moreover, Mst1 knockout protected cardiomyocytes against apoptosis in diabetic cardiomyopathy. 19, 20 However, the effect of cardiac-specific Mst1 knockout (Mst1 Δ/Δ ) in Ang II-induced cardiac apoptosis and the underlying mechanisms are not well understood.
We addressed this in the present study by investigating whether cardiac-specific Mst1 knockout can alleviate Ang II-induced cardiomyocyte apoptosis. Furthermore, we tested the underlying mechanisms that Mst1-specific knockout effectively counteracted Ang IIinduced dissociation of Trx from ASK1, thus inhibiting ASK1/JNK signalling-mediated activation of cardiomyocyte apoptosis.
| MATERIALS AND METHODS
For methods, materials and ethics statement in detail, please refer to the electronic supplementary material (ESM) Methods.
| Cardiomyocyte-specific Mst1 knockout mice
Cardiomyocyte-specific Mst1 knockout (Mst1 Δ/Δ ) mice were generated by standard Cre-LoxP-based gene targeting strategies. The final targeting vector (LoxP sites are A12242 to T12275 and A6695 to T6728; Exons are G13681 to A13724, T13561 to T13620, C7270 to G7320 and G4350 to G4478) for Mst1-conditional knockout was constructed and subsequently delivered to ES cells (C57BL/6 background).
Then some clones were selected for blastocyst microinjection, followed by chimera production. Founders were confirmed as germline- Figure S1 to S2 for details.
| Animal model
Mice were anaesthetized with 2% isoflurane, and a mini-osmotic pump (Alzet osmotic pump; BT-258, 2006) was implanted subcutaneously between the scapulae. In Ang II-treated groups, pumps were infused with Ang II (Merck1656, 1000 ng/kg per/min) for 46 days. 
| Mean arterial pressure
Mean arterial pressure (MAP) was measured by non-invasive tail cuff system (Softron BP-2010A, China) every 2 days.
| Echocardiography
Echocardiography was conducted in M-mode using an echocardiography system with a 15 MHz linear transducer (Vevo 2100, Canada) before execution. 20 
| Histological analyses
Heart specimens were fixed with formalin, embedded in paraffin, and sectioned at 6 μm thickness as previously described. 
| Fluorescence detection of Mst1
Fluorescence microscopic detection of Mst1 (ab51134; Abcam) was conducted according to the manufacturer's instructions. were measured using commercial assay kits according to manufacturer's Instructions.
2.14 | Assessment of primary cardiomyocyte apoptosis As described previously, TUNEL staining was performed with fluorescein-dUTP (In Situ Cell Death Detection Kit, Roche Diagnostics)
for apoptotic cell nuclei and DAPI stained cell nuclei. 20 Besides, apoptosis was induced by adding H 2 O 2 (12.5 μM, 100 μM and 800 μM) into 1 mL fresh medium for 4 hours as external positive control.
| AO/EB staining
Cardiomyocytes cultured on confocal dishes were treated with 20 μL AO/ EB solution (10 μL of AO; 10 μL of EB) (Solarbio, China) and incubated for 5 minutes at 37°C, and then examined by fluorescence microscope.
| Detection of JNK nuclear translocation in vitro
Primary antibody JNK (1:300, ab179461, Abcam) was employed to analyse the ratio of JNK nuclear translocation in primary cardiomyocyte. For details, see ESM Methods.
| Western blot evaluation
Protein was extracted from myocardial tissues or primary cardiomyocytes. Protein quantitation was modified by Bradford assay (BioRad Laboratories, Hercules, USA). See ESM Methods for detailed methods and materials.
| Detect Trx/ASK1 interaction in myocardium
The co-immunoprecipitation of Trx and ASK1 was performed following the protocol. 22, 23 See ESM Methods for details.
| Co-localisation of Trx and ASK1
In cardiac muscle, the sequential method of immunofluorescence double stainings was used to assess co-localization of Trx and ASK1.
See ESM Methods for details.
| Statistics
The results were analysed and quantified by Image Pro plus 6.0 software. Analyses of differences between groups were carried out using CHENG ET AL.
| 545 unpaired Student's t test, one-way ANOVA followed by a Fisher's post hoc comparison test. Continuous variables were expressed as mean ± standard error of mean (SEM). Two-sided tests were used throughout this study, and a P value of less than 0.05 was considered as significant. Statistical analyses were done using GraphPad Prism 5.01.
3 | RESULTS
| Mst1 knockout inhibits Ang II-induced cardiomyocyte apoptosis in vivo
The terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay revealed that Ang II administration aggravated cardiomyocte apoptosis, as evidenced by the increased apoptotic index in Ang II+Mst1 fl/fl mice relative to controls ( Figure 1A ). Importantly, cardiac-specific Mst1 knockout decreased AngII-induced myocardial apoptosis relative to Ang II+Mst1 fl/fl mice ( Figure 1A ).
We also evaluated the effect of Mst1 deficiency on the expression of apoptosis-related proteins by western blotting ( Figure 1B ).
The ratios of cleaved caspase-3/caspase-3 and B cell lymphoma 2-associated X protein (Bax) were higher in the Ang II+Mst1 fl/fl group than in control mice ( Figure 1B ). These results also suggest that Mst1-specific knockout in the presence of Ang II suppressed apoptosis ( Figure 1B ).
Moreover, Ang II stimulated the expression of p47 phox (Figure 1C) , a NADPH oxidase cytosolic subunit that plays an important role in the production of ROS and oxidative stress response. 24 Interestingly, Mst1 knockout attenuated the protein level of p47 phox in mice subjected to chronic Ang II infusion ( Figure 1C ). Taken together, these results indicate that the reversal of JNK phosphorylation by cardiomyocyte-specific Mst1 knockout leading to the attenuation of Ang II-induced cardiomyocyte apoptosis is dependent on the suppression of Ang II-triggered ROS production.
3.5 | Mst1-specific knockout failed to reduce Ang
II-induced hypertension
There were no significant differences in MAP between all groups before chronic Ang II infusion. Six weeks later, the Ang II groups had higher MAP compared to the corresponding control groups (ESM Figure S5A-B) . However, there were no significant differences in Figure S5A-B) .
| Mst1 knockdown decreases Ang II-induced cardiomyocyte apoptosis in vitro
Transduction of neonatal mouse cardiomyocytes with adenovirus harbouring short hairpin RNA against Mst1 abolished Mst1 expression ( Figure 4A and B) .
We evaluated the protein levels of cleaved caspase-3 and Bax by western blotting and found similar trends in cleaved caspase-3/caspase-3 and Bax/glyceraldehyde 3-phosphate dehydrogenase (GAPDH) ratios to those observed in vivo. Mst1 knockdown alleviated Ang II-induced primary cardiomyocyte apoptosis, as evidenced by the downregulation of cleaved caspase-3 and Bax in Ang II-treated primary cardiomyocytes ( Figure 4A ).
The degree of cellular damage in cardiomyocytes was estimated by Acridine Orange/Ethidium Bromide (AO/EB) stainings. There were three types of primary cardiomyocyte after AO/EB stainings: live cardiomyocyte (appearing green), live apoptotic cardiomyocyte (appearing dark yellow), and necrotic cardiomyocyte (appearing red). 25 The ratio of apoptotic cardiomyocytes+necrotic cardiomyocytes/total cardiomyocytes was increased by Ang II treatment ( Figure 4C ). Importantly, Mst1 knockdown attenuated Ang II-induced primary cardiomyocyte damage, as evidenced by the decreased numbers of apoptotic cardiomyocytes+necrotic cardiomyocytes ( Figure 4C ).
Furthermore, the results of TUNEL assay showed that Ang II induced primary cardiomyocyte apoptosis while Mst1 knockdown abrogated this effect, consistent with in vivo findings ( Figure 4D ).
| Mst1 knockdown reverses ROS-dependent JNK activation to alleviate Ang II-induced cardiomyocyte apoptosis in vitro
To determine whether Mst1 knockdown suppresses intracellular ROS production in primary cardiomyocytes, we examined intracellular ROS levels using the fluorescent probe 2′, 7′-dichlorofluorescin diacetate (DCFH-DA). NAC treatment and Mst1 knockdown reversed the Ang II-induced increase in intracellular ROS level (Figure 5A) . Interestingly, Mst1 knockdown failed to further decrease ROS production following NAC treatment ( Figure 5A ).
To investigate the role of JNK signalling in Ang II-induced cardiomyocyte apoptosis, we examined JNK nuclear translocation by immunofluorescence analysis and found that it was enhanced in the presence of Ang II ( Figure 5B ). This was reversed by NAC treatment or Mst1 knockdown ( Figure 5B ). Importantly, in Ang II-treated primary cardiomyocytes, Mst1 knockdown failed to further suppress JNK nuclear translocation after NAC treatment ( Figure 5 , B).
We next evaluated the expression of apoptosis-related proteins in primary cardiomyocytes by western blotting. Ang II-induced the phosphorylation of JNK (Thr183/Tyr185) and ERK1/2, whereas NAC treatment abolished the activation of JNK and ERK1/2 ( Figure 5C ). Mst1 knockdown reversed JNK activation (Thr183/Tyr185) in the presence of Ang II but had no effect on ERK1/2 phosphorylation status, which is in accordance with the in vivo results ( Figure 5C ). Importantly, in Ang II-treated primary cardiomyocytes, Mst1 knockdown did not further reverse JNK phosphorylation after NAC treatment ( Figure 5C ).
These results indicate that the protective effect of Mst1 deficiency against primary cardiomyocyte apoptosis caused by Ang II involves suppressing the generation of ROS.
| Mst1 knockdown improves mitochondrial metabolism by inhibiting Ang II-induced ROS production
Mst1 deficiency decreased Ang II-induced intracellular ROS production, as seen by the increased levels of MDA and T-AOC and downregulation of SOD (ESM Figure S6A-C) . Meanwhile, Mst1 deficiency enhanced mitochondrial metabolism (ESM Figure S6D) .
In Ang II-treated primary cardiomyocytes, loss of Mst1 did not further improve mitochondrial metabolism following treatment with NAC, indicating that Mst1 knockdown enhances mitochondrial metabolism by reversing Ang II-induced oxidative stress (ESM Figure S6D ).
| Ang II-induced JNK phosphorylation is reversed by Mst1 deficiency via enhanced binding of Trx to ASK1
In the presence of Ang II, cardiomyocyte-specific Mst1 knockout 
| DISCUSSION
HF is a common cause of death among patients with cardiovascular diseases. Despite progress in our understanding of the molecular and cellular mechanisms that contribute to HF and the development of many therapies, the incidence of HF remains high. 1 The major characteristics of heart failure include cardiomyocyte apoptosis and hypertrophy, which are largely the results of RAAS hyperactivation and the resultant production of ROS induced by the RAAS effector Ang II. [26] [27] [28] Our previous study showed the role of cardiac-specific Mst1 knockout in cardiac hypertrophy and cardiomyocyte autophagy; however, whether Mst1-specific knockout involved in Ang II-induced ROS production and cardiac apoptosis as well as the CHENG ET AL.
| 549 underlying mechanisms remain to be clarified. 29 In this study, we
showed that cardiomyocyte-specific Mst1 knockout attenuates Ang IIinduced cardiomyocyte apoptosis by blocking JNK signalling, an effect that is dependent on ROS clearance. Cardiac-specific Mst1 knockout also enhanced the binding of Trx to ASK1, thereby suppressing ASK1-JNK signalling activation and inhibiting cardiomyocyte apoptosis.
Interestingly, cardiac-specific Mst1 knockout failed to reduce Ang IIinduced hypertension, which signifies that the role and mechanisms of Mst1-specific deletion alleviating Ang II-induced cardiomyocyte apoptosis were independent of the reduction of arterial pressure.
Some previous studies suggested that ROS induced cell apoptosis and NAC restored the ROS-mediated apoptosis. 30 However, Maiko Suzuki and colleagues reported that ROS also promotes antioxidant defense and plays a protective role in the posttranslational modification of proteins; NAC also induced apoptosis via mitochondrial-dependent means. 31 Therefore, the roles and underlying mechanisms of intracellular ROS and NAC in various cell types remain elusive. 31 In this study, Ang II administration triggered the production of intracellular ROS, leading to cardiomyocyte apoptosis and cardiac dysfunction; this effect was abrogated by NAC and by cardiomyocyte-specific Mst1 knockout, which resulted in the downregulation of p47 phox , an NAD(P)H oxidase subunit. P47 phox is required for activation of the latent NADPH oxidase, a multicomponent enzyme that is activated to produce superoxide anion and ROS. 24 Thus, Mst1 deficiency exerts anti-apoptosis effect via inhibiting Ang II-induced ROS production. This was found to be mediated via inhibiting activation of p47 phox and JNK signalling. Interestingly, the phenomenon that Ang II slightly decreased the level of p-Mst1/ Mst1 was observed in this study and our previous works, which could be interpreted as a host-defense mechanism, a spontaneous repair of cardiomyocyte to try to attenuate the Ang II-triggered oxidative stress and subsequent heart failure. 29 MAPK pathways act as the downstream of ROS signalling under many pathological conditions. 32 Increased phosphorylation of Mst1 (Thr183) was shown to activate upstream of MAPK kinases, sequentially altering the phosphorylation status of MAPKs. 32 Our study suggested that cardiomyocyte-specific Mst1 knockout abrogated the phosphorylation of Mst1 (Thr183), thus inhibiting the phosphorylation of JNK (Thr183/Tyr185); however, Mst1 deficiency failed to change Erk1/2 phosphorylation, suggesting that Mst1-specific knockout had the specificity of MAPKs signalling transduction.
This study has indicated that JNK phosphorylation results from ROS-induced apoptosis; conversely, suppressing JNK activation can block the initiation of apoptosis. Excess ROS production induced by Ang II can also perturb mitochondrial function; this was confirmed in the present study in primary cardiomyocyte, and was found to be reversed by Mst1 deficiency.
ASK1 is activated by ROS generated by mitochondria in the presence of Ang II. 33, 34 Previous studies also showed that ASK1 relays apoptotic signals by directly phosphorylating JNK. 33, 34 Trx, a highly Based on this, the potential binding sites between Mst1 and ASK1/ Trx could be explored in future plan.
In conclusion, we demonstrate here that cardiac-specific Mst1 knockout reduced Ang II-triggered ROS production and alleviated cardiomyocyte apoptosis by counteracting the Ang II-induced dissociation of Trx from ASK1 and thereby inhibiting ASK1/JNK-mediated activation of apoptosis. These findings provide novel insight into the molecular link between the RAAS and cardiac apoptosis and suggest Mst1 as a potential therapeutic target for preventing HF.
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F I G U R E 3 Mst1 deficiency inhibits ROS-mediated JNK phosphorylation to attenuate Ang II-induced cardiomyocyte apoptosis in vivo. A: Measurements of ROS production (n = 6). The effects of ROS generations were measured by the DHE fluorescent probe, the levels of intracellular MDA, SOD, and T-AOC. Histogram: Relative DHE fluorescence intensity, MDA levels (nmol/mgprot), SOD levels (U/mgprot), and T-AOC levels (mmol/mgprot). B: Representative images of p-JNK immunohistochemistry (n = 6). Histogram: p-JNK positive rate (%). C: Analyse myocardial pathological changes by H&E staining (n = 6 
